Guide to Clinical Trials B. Spilker, New York: Raven Press, 1991 , 1156 This enormous single author book is written to explain the practical details of clinical trials. The 133 chapters cover the details of trial design, writing a protocol, aspects of statistics, the interpretation of response and efficacy data, how to publish results and the regulatory and managerial aspects of trials.
Within the chapters Dr Spilker tries to explain the basic principles of what is to be discussed or investigated and to give a flow diagram or table of how to go about getting the data, or analysing it. He writes clearly but the text is often rather tediously generalised so that, for example, in the discussion of trial size there is a brief resume of a and P errors, but little insight into how the trial size relates to the clinical importance of the question (whether, for example, the size of any difference needs to be quantified precisely). There is little insight into the importance of statistical methodology generally. Some of the chapters appear strangely out of place. There are for example 33 pages on preparing an article for publication and assessing the quality of a paper you have read. Much of this consists of pages of tables. There is a long series of chapters on the goals and strategies of marketing and drug development which may be of interest to pharmaceutical companies but seem somewhat beside the point for clinicians.
Almost everything and anything to do with trials is touched on in this book. That is both a strength and a weakness. I suppose that the professional group who would find it most valuable are the clinical co-ordinators of research in pharmaceutical companies, especially in the USA (there are concessions to regulatory authorities elsewhere in the world). I don't really recommend it for oncologists involved in trials since it is not detailed enough in certain key areas and contains much information and advice which is redundant for cancer trials. cope with when he found a more traditionally paternalistic doctor who was prepared to make the treatment decisions for him. In section 2, various specific problem areas are covered. For example, in his introduction the editor touches on the difficulty of testing new drugs in chemosensitive tumours. If one uses the new drug first and it turns out to be ineffective then there will be a delay in introducing standard effective treatment and drug resistance may be induced. On the other hand if one waits till the patient no longer responds to standard treatment, then multiple drug resistance may have developed and the true efficacy of the new drug will not emerge. Williams suggests that trials should randomise patients to the new drug followed by the phase II drug on progression. This is a very unwieldy solution which would not provide any general truths about the safety or not of using new drugs in previously untreated patients and could not possibly be repeated for each drug because of the large number of patients that would be required. Unfortunately this problem is not developed further in the book and is the principal omission in what is otherwise a comprehensive examination of the dilemmas facing new cancer drug investigators. Section 3 deals with the pharmaceutical industry and economic considerations. It is the weakest section. The chapter on economic evaluation of cancer treatments is, in places, banal (e.g. Figure 2 ), in others confusing ('The efficacy and effectiveness of chemotherapy in solid tumours are ambiguous'), and in others still poorly described (Figure 4) . A discussion of the implications for Fine needle aspiration cytology is used increasingly in the investigation and management of breast disease, and to be successful, requires the combined skills of clinician, radiologist and cytopathologist.
First published in Italy, in 1989, this book is particularly directed to the practical problems of obtaining material from breast lesions and providing adequate preparations for cytopathological evaluation. There is useful discussion of the role of the cytopathologist, with guidance on the interpretation and practical application of results. Although mainly concerned with FNA, the indications for examination of cyst fluids and nipple discharge are also presented in the light of considerable clinical experience.
In addition the 14 sections (120 pages) with references and illustrations cover a number of other aspects, including historical background, physical examination of the breast, use of ultrasound and stereotaxis, and the measurement of oestrogen-receptor content. Possible hazards of needle aspira-
